Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy, safety, and tolerability of
Levomilnacipran ER fixed doses versus placebo in the treatment of outpatients with major
depressive disorder.